Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $94.00
Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its price target hoisted by Stifel Nicolaus from $78.00 to $94.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has a buy rating on the stock. Several other equities research analysts have also commented on RYTM. Needham & Company LLC increased their price […]
Rhythm Pharmaceuticals (NASDAQ:RYTM – Free Report) had its price target hoisted by Stifel Nicolaus from $78.00 to $94.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has a buy rating on the stock. Several other equities research analysts have also commented on RYTM. Needham & Company LLC increased their price […]
